Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Fassan, M., Cui, R., Gasparini, P., Mescoli, C., Guzzardo, V., Vicentini, C., Munari, G., Loupakis, F., Lonardi, S., Braconi, C., et al. (2019). miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis. Transl oncol, Vol.12 (2), pp. 282-291.  show abstract

Smyth, E.C., Nyamundanda, G., Cunningham, D., Fontana, E., Ragulan, C., Tan, I.B., Lin, S.J., Wotherspoon, A., Nankivell, M., Fassan, M., et al. (2018). A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Ann oncol, Vol.29 (12), pp. 2356-2362.  show abstract

Moorcraft, S.Y., Gonzalez de Castro, D., Cunningham, D., Jones, T., Walker, B.A., Peckitt, C., Yuan, L.C., Frampton, M., Begum, R., Eltahir, Z., et al. (2018). Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice. Ann oncol, Vol.29 (1), pp. 230-236.  show abstract

Mensah, A.A., Cascione, L., Gaudio, E., Tarantelli, C., Bomben, R., Bernasconi, E., Zito, D., Lampis, A., Hahne, J.C., Rinaldi, A., et al. (2018). Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma. Haematologica, .  show abstract

Lampis, A., Carotenuto, P., Vlachogiannis, G., Cascione, L., Hedayat, S., Burke, R., Clarke, P., Bosma, E., Simbolo, M., Scarpa, A., et al. (2018). MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma. Gastroenterology, Vol.154 (4), pp. 1066-1079.e5.  show abstract

Smyth, E., Khan, K. & Valeri, N. (2018). Translational research and application of basic biology to clinical trial development in GI cancers. Ann transl med, Vol.6 (9), p. 164.  show abstract

Davarzani, N., Hutchins, G.G., West, N.P., Hewitt, L.C., Nankivell, M., Cunningham, D., Allum, W.H., Smyth, E., Valeri, N., Langley, R.E., et al. (2018). Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. Histopathology, Vol.72 (7), pp. 1180-1188.  show abstract

Ghidini, M., Hahne, J.C., Frizziero, M., Tomasello, G., Trevisani, F., Lampis, A., Passalacqua, R. & Valeri, N. (2018). MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours. Target oncol, Vol.13 (4), pp. 423-436.  show abstract

Khan, K., Rata, M., Cunningham, D., Koh, D.-., Tunariu, N., Hahne, J.C., Vlachogiannis, G., Hedayat, S., Marchetti, S., Lampis, A., et al. (2018). Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study. Gut, Vol.67 (8), pp. 1484-1492.  show abstract

Salati, M., Valeri, N., Spallanzani, A., Braconi, C. & Cascinu, S. (2018). Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications. Eur j surg oncol, .  show abstract

Khan, K.H., Cunningham, D., Werner, B., Vlachogiannis, G., Spiteri, I., Heide, T., Mateos, J.F., Vatsiou, A., Lampis, A., Damavandi, M.D., et al. (2018). Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial. Cancer discov, Vol.8 (10), pp. 1270-1285.  show abstract

Ratti, M., Lampis, A., Hahne, J.C., Passalacqua, R. & Valeri, N. (2018). Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell mol life sci, Vol.75 (22), pp. 4151-4162.  show abstract

Fanelli, G.N., Gasparini, P., Coati, I., Cui, R., Pakula, H., Chowdhury, B., Valeri, N., Loupakis, F., Kupcinskas, J., Cappellesso, R., et al. (2018). LONG-NONCODING RNAs in gastroesophageal cancers. Noncoding rna res, Vol.3 (4), pp. 195-212.  show abstract

Sundar, R., Miranda, S., Rodrigues, D.N., Chénard-Poirier, M., Dolling, D., Clarke, M., Figueiredo, I., Bertan, C., Yuan, W., Ferreira, A., et al. (2018). Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer. Clin colorectal cancer, Vol.17 (4), pp. 280-284.  show abstract

Lote, H., Valeri, N. & Chau, I. (2018). HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer. World j gastrointest oncol, Vol.10 (7), pp. 159-171.  show abstract

Wagner, S., Vlachogiannis, G., De Haven Brandon, A., Valenti, M., Box, G., Jenkins, L., Mancusi, C., Self, A., Manodoro, F., Assiotis, I., et al. (2018). Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Oncogene, .  show abstract

Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science, Vol.359 (6378), pp. 920-926.  show abstract

Sclafani, F., Chau, I., Cunningham, D., Hahne, J.C., Vlachogiannis, G., Eltahir, Z., Lampis, A., Braconi, C., Kalaitzaki, E., De Castro, D.G., et al. (2018). KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Sci rep, Vol.8 (1), p. 1445.  show abstract

Khan, K., Rane, J.K., Cunningham, D., Rao, S., Watkins, D., Starling, N., Kalaitzaki, E., Forster, M., Braconi, C., Valeri, N., et al. (2018). Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience. Clin colorectal cancer, .  show abstract

Fassan, M., Vianello, L., Sacchi, D., Fanelli, G.N., Munari, G., Scarpa, M., Cappellesso, R., Loupakis, F., Lanza, C., Salmaso, R., et al. (2018). Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer cell int, Vol.18, p. 131.  show abstract

Hahne, J.C. & Valeri, N. (2018). Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Front oncol, Vol.8, p. 226.  show abstract

Fassan, M., Saraggi, D., Balsamo, L., Realdon, S., Scarpa, M., Castoro, C., Coati, I., Salmaso, R., Farinati, F., Guzzardo, V., et al. (2017). Early miR-223 Upregulation in Gastroesophageal Carcinogenesis. Am j clin pathol, Vol.147 (3), pp. 301-308.  show abstract

Smyth, E.C., Wotherspoon, A., Peckitt, C., Gonzalez, D., Hulkki-Wilson, S., Eltahir, Z., Fassan, M., Rugge, M., Valeri, N., Okines, A., et al. (2017). Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial. Jama oncol, Vol.3 (9), pp. 1197-1203.  show abstract

Lote, H., Spiteri, I., Ermini, L., Vatsiou, A., Roy, A., McDonald, A., Maka, N., Balsitis, M., Bose, N., Simbolo, M., et al. (2017). Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer. Ann oncol, Vol.28 (6), pp. 1243-1249.  show abstract

Sundar, R., Valeri, N., Harrington, K.J. & Yap, T.A. (2017). Combining Molecularly Targeted Agents: Is More Always Better?. Clin cancer res, Vol.23 (5), pp. 1123-1125.  show abstract

Saraggi, D., Fassan, M., Mescoli, C., Scarpa, M., Valeri, N., Michielan, A., D'Incá, R. & Rugge, M. (2017). The molecular landscape of colitis-associated carcinogenesis. Dig liver dis, Vol.49 (4), pp. 326-330.  show abstract

Carotenuto, P., Fassan, M., Pandolfo, R., Lampis, A., Vicentini, C., Cascione, L., Paulus-Hock, V., Boulter, L., Guest, R., Quagliata, L., et al. (2017). Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. Gut, Vol.66 (7), pp. 1268-1277.  show abstract

Ghidini, M., Cascione, L., Carotenuto, P., Lampis, A., Trevisani, F., Previdi, M.C., Hahne, J.C., Said-Huntingford, I., Raj, M., Zerbi, A., et al. (2017). Characterisation of the immune-related transcriptome in resected biliary tract cancers. Eur j cancer, Vol.86, pp. 158-165.  show abstract

Smyth, E., Zhang, S., Cunningham, D., Wotherspoon, A., Soong, R., Peckitt, C., Valeri, N., Fassan, M., Rugge, M., Okines, A., et al. (2017). Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. Clin cancer res, Vol.23 (24), pp. 7543-7549.  show abstract

Tomasello, G., Valeri, N., Ghidini, M., Smyth, E.C., Liguigli, W., Toppo, L., Mattioli, R., Curti, A., Hahne, J.C., Negri, F.M., et al. (2017). First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study. Oncotarget, Vol.8 (67), pp. 111795-111806.  show abstract

Battersby, N.J., Dattani, M., Rao, S., Cunningham, D., Tait, D., Adams, R., Moran, B.J., Khakoo, S., Tekkis, P., Rasheed, S., et al. (2017). A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials, Vol.18 (1), p. 394.  show abstract

Saraggi, D., Fassan, M., Bornschein, J., Farinati, F., Realdon, S., Valeri, N. & Rugge, M. (2016). From Barrett metaplasia to esophageal adenocarcinoma: the molecular background. Histol histopathol, Vol.31 (1), pp. 25-32.  show abstract

Sclafani, F., Chau, I., Cunningham, D., Lampis, A., Hahne, J.C., Ghidini, M., Lote, H., Zito, D., Tabernero, J., Glimelius, B., et al. (2016). Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients. Carcinogenesis, Vol.37 (9), pp. 852-857.  show abstract

Smyth, E.C., Fassan, M., Cunningham, D., Allum, W.H., Okines, A.F., Lampis, A., Hahne, J.C., Rugge, M., Peckitt, C., Nankivell, M., et al. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. J clin oncol, Vol.34 (23), pp. 2721-2727.  show abstract

Trevisani, F., Ghidini, M., Larcher, A., Lampis, A., Lote, H., Manunta, P., Alibrandi, M.T., Zagato, L., Citterio, L., Dell'Antonio, G., et al. (2016). MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. Br j cancer, Vol.115 (11), pp. 1343-1350.  show abstract

Fassan, M., Saraggi, D., Balsamo, L., Cascione, L., Castoro, C., Coati, I., De Bernard, M., Farinati, F., Guzzardo, V., Valeri, N., et al. (2016). Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget, Vol.7 (4), pp. 4915-4924.  show abstract

Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J.C., Braconi, C., Tabernero, J., Glimelius, B., Cervantes, A., et al. (2015). Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial. Ann oncol, Vol.26 (9), pp. 1936-1941.  show abstract

Slattery, M.L., Herrick, J.S., Mullany, L.E., Valeri, N., Stevens, J., Caan, B.J., Samowitz, W. & Wolff, R.K. (2015). An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int j cancer, Vol.137 (2), pp. 428-438.  show abstract

Cordero, J.B., Ridgway, R.A., Valeri, N., Nixon, C., Frame, M.C., Muller, W.J., Vidal, M. & Sansom, O.J. (2014). c-Src drives intestinal regeneration and transformation. Embo j, Vol.33 (13), pp. 1474-1491.  show abstract

Ryan, B.M., Wolff, R.K., Valeri, N., Khan, M., Robinson, D., Paone, A., Bowman, E.D., Lundgreen, A., Caan, B., Potter, J., et al. (2014). An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer epidemiol, Vol.38 (5), pp. 583-590.  show abstract

Valeri, N., Braconi, C., Gasparini, P., Murgia, C., Lampis, A., Paulus-Hock, V., Hart, J.R., Ueno, L., Grivennikov, S.I., Lovat, F., et al. (2014). MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer cell, Vol.25 (4), pp. 469-483.

Fassan, M., Dall'Olmo, L., Galasso, M., Braconi, C., Pizzi, M., Realdon, S., Volinia, S., Valeri, N., Gasparini, P., Baffa, R., et al. (2014). Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget, Vol.5 (16), pp. 7162-7171.

Valeri, N., Braconi, C., Gasparini, P., Grivennikow, S., Hart, J.R., Paone, A., Lovat, F. & Fabbri, M. (2012). Anti-miR-135b in colon cancer treatment: Results from a preclinical study. Journal of clinical oncology, Vol.30 (4).

Valeri, N., Braconi, C., Gasparini, P., Grivennikow, S., Hart, J.R., Paone, A., Lovat, F., Fabbri, M., Gafa', R., Nuovo, G., et al. (2012). Anti-miR-135b in colon cancer treatment: Results from a preclinical study. J clin oncol, Vol.30 (4_suppl), p. 457.  show abstract

Nuovo, G.J., Garofalo, M., Valeri, N., Roulstone, V., Volinia, S., Cohn, D.E., Phelps, M., Harrington, K.J., Vile, R., Melcher, A., et al. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Mod pathol, Vol.25 (10), pp. 1333-1344.  show abstract

Ryan, B.M., McClary, A.C., Valeri, N., Robinson, D., Paone, A., Bowman, E.D., Robles, A.I., Croce, C. & Harris, C.C. (2012). rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. Plos one, Vol.7 (5), p. e36306.  show abstract

Braconi, C., Kogure, T., Valeri, N., Gasparini, P., Huang, N., Nuovo, G., Terracciano, L., Croce, C.M. & Patel, T. (2011). Effect of the ultraconserved noncoding RNA uc 338 on cellular growth of hepatocarcinoma. Journal of clinical oncology, Vol.29 (4).

Valeri, N., Gasparini, P., Braconi, C., Lovat, F., Paone, A., Fabbri, M., Nuovo, G., Fishel, R. & Croce, C.M. (2011). Effect of miR-21 on resistance to 5-fluorouracil and regulation of MSH2. Journal of clinical oncology, Vol.29 (4).

Voltan, R., di Iasio, M.G., Bosco, R., Valeri, N., Pekarski, Y., Tiribelli, M., Secchiero, P. & Zauli, G. (2011). Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells. Clin cancer res, Vol.17 (17), pp. 5649-5655.  show abstract

Valeri, N., Gasparini, P., Braconi, C., Lovat, F., Paone, A., Fabbri, M., Nuovo, G., Fishel, R. & Croce, C.M. (2011). Effect of miR-21 on resistance to 5-fluorouracil and regulation of MSH2. J clin oncol, Vol.29 (4_suppl), p. 431.  show abstract

Braconi, C., Kogure, T., Valeri, N., Gasparini, P., Huang, N., Nuovo, G., Terracciano, L., Croce, C.M. & Patel, T. (2011). Effect of the ultraconserved noncoding RNA uc 338 on cellular growth of hepatocarcinoma. J clin oncol, Vol.29 (4_suppl), p. 202.  show abstract

Fabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M.S., Rossi, S., Barbarotto, E., Cimmino, A., Adair, B., Wojcik, S.E., et al. (2011). Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Jama, Vol.305 (1), pp. 59-67.  show abstract

Braconi, C., Valeri, N., Kogure, T., Gasparini, P., Huang, N., Nuovo, G.J., Terracciano, L., Croce, C.M. & Patel, T. (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc natl acad sci u s a, Vol.108 (2), pp. 786-791.  show abstract

Lovat, F., Valeri, N. & Croce, C.M. (2011). MicroRNAs in the pathogenesis of cancer. Semin oncol, Vol.38 (6), pp. 724-733.  show abstract

Braconi, C., Kogure, T., Valeri, N., Nuovo, G., Costinean, S., Croce, C.M. & Patel, T. (2011). Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC). Cancer research, Vol.71.

Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C.M. & Patel, T., et al. (2011). microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, Vol.30 (47), pp. 4750-4756.  show abstract

Braconi, C., Valeri, N., Gasparini, P., Huang, N., Taccioli, C., Nuovo, G., Suzuki, T., Croce, C.M. & Patel, T. (2010). Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin cancer res, Vol.16 (3), pp. 957-966.  show abstract

Braconi, C., Kogure, T., Valeri, N., Huang, N., Gasparini, P., Nuovo, G., Terracciano, L., Croce, C.M. & Patel, T. (2010). Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth. Cancer research, Vol.70.

Braconi, C., Kogure, T., Valeri, N., Huang, N., Gasparini, P., Nuovo, G., Terracciano, L., Croce, C.M. & Patel, T. (2010). Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth. Cancer research, Vol.70.

Cohn, D.E., Fabbri, M., Valeri, N., Alder, H., Ivanov, I., Liu, C.-., Croce, C.M. & Resnick, K.E. (2010). Comprehensive miRNA profiling of surgically staged endometrial cancer. Am j obstet gynecol, Vol.202 (6), pp. 656.e1-656.e8.  show abstract

Valeri, N., Gasparini, P., Braconi, C., Paone, A., Lovat, F., Fabbri, M., Sumani, K.M., Alder, H., Amadori, D., Patel, T., et al. (2010). MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc natl acad sci u s a, Vol.107 (49), pp. 21098-21103.  show abstract

Valeri, N., Gasparini, P., Fabbri, M., Braconi, C., Veronese, A., Lovat, F., Adair, B., Vannini, I., Fanini, F., Bottoni, A., et al. (2010). Modulation of mismatch repair and genomic stability by miR-155. Proc natl acad sci u s a, Vol.107 (15), pp. 6982-6987.  show abstract

Fabbri, M., Adair, B., Wernicke, D., Garzon, R., Valeri, N., Cimmino, A., Zanesi, N. & Croce, C. (2009). MicroRNA 29 family restores estrogen receptor and selective estrogen receptors regulators (SERMs) sensitivity in breast cancer. Cancer research, Vol.69.

Fabbri, M., Valeri, N. & Calin, G.A. (2009). MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis, Vol.30 (6), pp. 912-917.  show abstract

Valeri, N., Croce, C.M. & Fabbri, M. (2009). Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer genomics proteomics, Vol.6 (4), pp. 195-204.  show abstract

Valeri, N., Vannini, I., Fanini, F., Calore, F., Adair, B. & Fabbri, M. (2009). Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm genome, Vol.20 (9-10), pp. 573-580.  show abstract

Resnick, K.E., Fabbri, M., Valeri, N., Alder, H., Taccioli, C., Liu, C.-., Cohn, D.E. & Croce, C.M. (2008). MiRNA profile in stage 1, surgically staged endometrial cancer and predicted downstream targets. Gynecologic oncology, Vol.108 (3), pp. S11-S11.

Braconi, C., Bracci, R., Bearzi, I., Bianchi, F., Costagliola, A., Catalani, R., Mandolesi, A., Ranaldi, R., Galizia, E., Cascinu, S., et al. (2008). KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Ann oncol, Vol.19 (4), pp. 706-710.  show abstract

Braconi, C., Bracci, R., Bearzi, I., Bianchi, F., Sabato, S., Mandolesi, A., Belvederesi, L., Cascinu, S., Valeri, N. & Cellerino, R., et al. (2008). Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. Ann oncol, Vol.19 (7), pp. 1293-1298.  show abstract

Cascinu, S., Verdecchia, L., Valeri, N., Berardi, R. & Scartozzi, M. (2006). New target therapies in advanced pancreatic cancer. Ann oncol, Vol.17 Suppl 5, pp. v148-v152.  show abstract

Valeri, N., Battelli, N., Mariotti, C., Santinelli, A., Siquini, W., Gusella, P., Braconi, C., Lippe, P. & Cascinu Prof, S. (2006). CEA as a prognostic factor in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy. J clin oncol, Vol.24 (18_suppl), p. 10705.  show abstract


Book Chapters

Hahne, J.C., Honig, A., Engel, J.B., Lampis, A. & Valeri, N. Analysing Molecular Mechanism Related to Therapy- Resistance in In-vitro Models of Ovarian Cancer. Gynecologic Cancers - Basic Sciences, Clinical and Therapeutic Perspectives. InTech, ISBN: 9789535142782.


Conferences

Smyth, E.C., Kouvelakis, K., Cunningham, D., Peckitt, C., Nankivell, M.G., Allum, W.H., Wotherspoon, A., Hahne, J., Lampis, A., Langley, R.E., et al. (2018). Single nucleotide polymorphisms of mir-608, LCS-6, and overall survival in the MAGIC trial., JOURNAL OF CLINICAL ONCOLOGY, Vol.36 (4).

Hutchins, G.G., Davarzani, N., West, N.P., Hewitt, L., Nankivell, M., Cunningham, D., Allum, W.H., Smyth, E., Valeri, N., Langley, R.E., et al. (2018). Defining the Clinical Value of Pathological Lymph Node Status and Primary Tumour Regression Grading Following Neoadjuvant Therapy in Oesophageal Cancer: Results from the MRC OE02 Trial, JOURNAL OF PATHOLOGY, Vol.246, p.S16.

Kuhnl, A., Peckitt, C., Patel, B., Ardeshna, K.M., Macheta, M.P., Radford, J., Johnson, R., Paneesha, S., Barton, S., Chau, I., et al. (2017). R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial, BLOOD, Vol.130.

Sclafani, F., Gollins, S., Cunningham, D., Wilson, S.H., Kouvelakis, K., Lopes, A., West, N., Quirke, P., Begum, R., Valeri, N., et al. (2017). FC gamma RIIa and FC gamma RIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial, ANNALS OF ONCOLOGY, Vol.28.

Khan, K.H., Rata, M., Koh, D.-., Tunariu, N., Collins, D.J., Chau, I., Watkins, D.J., Starling, N., Rao, S., Peckitt, C., et al. (2016). A prospective translational study investigating molecular predictors of resistance and response to regorafenib (REG) monotherapy in RAS mutant (mt) metastatic colorectal cancer (mCRC): Initial magnetic resonance imaging (MRI) sub-study result., JOURNAL OF CLINICAL ONCOLOGY, Vol.34 (4).

Damavandi, M.D., Braconi, C., Cascione, L., Lampis, A., Hahne, J., Murgia, C., Ghidini, M., Nyamundanda, G., Sadanandam, A., Croce, C., et al. (2015). Global gene expression profiling of mice tumor-derived organoids identifies key microRNAs and metabolic genes involved in CRC progression, CANCER RESEARCH, Vol.75.

Khan, K., Vlachogianis, G., Cunningham, D., Hahne, J., Darvish-Damavandi, M., Barton, S., Trevisani, F., Mentrast, G., Peckitt, C., Lampis, A., et al. (2015). Validation of the role of circulating tumor DNA (ctDNA) in tracking mechanisms of resistance to anti-EGFR monoclonal antibodies (AE-mABs): preliminary results of the PROSPECT-C prospective trial, CANCER RESEARCH, Vol.75.

Cheong, I.H., Lampis, A., Fassan, M., Paulus-Hock, V., Vicentini, C., Hahne, J., Cascione, L., Quagliata, L., Jamieson, T., Athineos, D., et al. (2015). THE LONG NON CODING RNA UC.158 MODULATES GROWTH OF Wnt/beta;-CATENIN DRIVEN HEPATOCELLULAR CARCINOMA (HCC), JOURNAL OF HEPATOLOGY, Vol.62, pp.S413-S414.

Trevisani, F., Ghidini, M., Manunta, P., Hahne, J., Lampis, A., Braconi, C., Alibrandi, M.T., Zagato, L., Cittero, L., Dell'antonio, G., et al. (2015). MICRORNA-200B AS PREDICTIVE BIOMARKER OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY, NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol.30.

Khan, K., Chau, I., Gerlinger, M., Valeri, N., Koh, D.-., Starling, N., Watkins, D., Rao, S., Tunariu, N., Fotiadis, N., et al. (2015). PROSPECT-R: A PROSPECTive translational study investigating molecular predictors of resistance and response to Regorafenib (REG) monotherapy in RAS mutant (mt) metastatic colorectal cancer (CRC), ANNALS OF ONCOLOGY, Vol.26.

Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J.C., Braconi, C., Tabernero, J., Glimelius, B., Cervantes, A., et al. (2015). Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial, EUROPEAN JOURNAL OF CANCER, Vol.51, p.S396.

Ghidini, M., Trevisani, F., Fassan, M., Cascione, L., Hahne, J.C., Lampis, A., Cheong, I.H., Scarpa, A., Vicentini, C., Zerbi, A., et al. (2015). Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs), ANNALS OF ONCOLOGY, Vol.26, p.97.

Moorcraft, S.Y., de Castro, D.G., Cunningham, D., Walker, B.A., Wilson, S.H., Perez, J.D., Peckitt, C., Wotherspoon, A., Begum, R., Valeri, N., et al. (2015). FOrMAT: Feasibility of a molecular characterization approach to treatment of patients (pts) with advanced gastrointestinal (GI) tumors, JOURNAL OF CLINICAL ONCOLOGY, Vol.33 (3).

Sclafani, F., Chau, I., Cunningham, D., Lampis, A., Hahne, J., Braconi, C., Peckitt, C., Gonzalez, D., Wilson, S.H., Capdevila, J., et al. (2015). Prognostic effect of a single nucleotide polymorphism (SNP) in MIR608 in patients with high-risk locally advanced rectal cancer (LARC): Results of the EXPERT-C trial., JOURNAL OF CLINICAL ONCOLOGY, Vol.33 (3).

Paulus-Hock, V., Lampis, A., Ferrari, G., Boulton, L., Guest, R., Athineos, D., Jamieson, T., Veronese, A., Visone, R., Evans, R., et al. (2014). THE ULTRACONSERVED NON CODING RNA UC.158 IS DOWNSTREAM OF THE WNT/beta-CATENIN PATHWAY IN LIVER CANCERS, JOURNAL OF HEPATOLOGY, Vol.60 (1), p.S88.

Braconi, C., Valeri, N., Gasparini, P., Jiang, J., Kogure, T., Croce, C., Schmittgen, T. & Patel, T. (2013). Transcribed ultraconserved regions are aberrantly expressed and can be modulated by interleukin 6 in cholangiocarcinoma, LANCET, Vol.381, p.26.

Valeri, N., Braconi, C., Gasparini, P., Hart, J., Grivennikov, S., Lovat, F., Lanza, G., Gafa, R., Nuovo, G., Frankel, W., et al. (2013). microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer, LANCET, Vol.381, p.17.


Patents and patent applications

Valeri, N. & Croce, C.M. Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155.